Janney Montgomery Scott LLC Buys 552 Shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Janney Montgomery Scott LLC increased its stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 8.2% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 7,251 shares of the company’s stock after purchasing an additional 552 shares during the period. Janney Montgomery Scott LLC’s holdings in iShares U.S. Pharmaceuticals ETF were worth $512,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently modified their holdings of IHE. Jones Financial Companies Lllp increased its stake in iShares U.S. Pharmaceuticals ETF by 74.6% in the fourth quarter. Jones Financial Companies Lllp now owns 30,913 shares of the company’s stock valued at $2,032,000 after acquiring an additional 13,209 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF in the 4th quarter valued at $4,472,000. One Capital Management LLC boosted its holdings in shares of iShares U.S. Pharmaceuticals ETF by 14.7% in the 4th quarter. One Capital Management LLC now owns 29,526 shares of the company’s stock valued at $1,940,000 after purchasing an additional 3,777 shares in the last quarter. HighTower Advisors LLC increased its stake in shares of iShares U.S. Pharmaceuticals ETF by 1.9% in the 4th quarter. HighTower Advisors LLC now owns 13,653 shares of the company’s stock valued at $897,000 after purchasing an additional 261 shares during the last quarter. Finally, Sequoia Financial Advisors LLC raised its holdings in shares of iShares U.S. Pharmaceuticals ETF by 19.1% during the 4th quarter. Sequoia Financial Advisors LLC now owns 3,433 shares of the company’s stock worth $226,000 after buying an additional 550 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Stock Up 0.6%

NYSEARCA:IHE opened at $66.59 on Thursday. iShares U.S. Pharmaceuticals ETF has a twelve month low of $58.97 and a twelve month high of $73.28. The stock’s 50-day simple moving average is $65.48 and its 200 day simple moving average is $67.02. The firm has a market capitalization of $562.69 million, a PE ratio of 22.74 and a beta of 0.70.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.